amphastar.com (AMPH): O‘sish sur’atiga tuzatilgan narx-foyda
Murakkab inhalatorlar ishlab chiqarishning vertikal integratsiyasi Amphastar Pharmaceuticals (AMPH) rahbariyatiga xarajatlarni optimallashtirish imkonini berdi, buni joriy metrika qiymati 2.71 bo'lgan PEG koeffitsiyenti tasdiqlaydi. Ushbu grafik takrorlanishi qiyin bo'lgan inyeksion vositalar bozorida tor segmentni egallash strategiyasini yoritib beradi. Yuqori texnologik to'siqlar va FDA tasdiqi arzon generik dori vositalaridan foydani ishonchli tarzda himoya qilib, biznesning barqaror o'sishini ta'minlaydi.
Amphastar Pharmaceuticals (AMPH) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Amphastar Pharmaceuticals|AMPH - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati amphastar.com|AMPH - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Amphastar|AMPH - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Amphastar Pharmaceuticals|Kritik likvidlik koeffitsiyenti amphastar.com
- foyda va bozor koeffitsiyentlari statistikasi:
AMPH - Sof foyda|Kutilayotgan sof daromad Amphastar Pharmaceuticals|AMPH - P/E multiplikatori|Forvard P/E multiplikatori Amphastar Corp|AMPH - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Amphastar|AMPH - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Amphastar Pharmaceuticals|AMPH - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi amphastar.com|AMPH - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Amphastar Pharmaceuticals
Kompaniyaning umumiy tahlili:AMPH Amphastar Pharmaceuticals Inc
Ushbu ko'rsatkich joriy bozor P/E koeffitsientini sof foyda o'sish sur'ati bilan solishtiradi va qiymat birdan past bo'lganda, yuqori o'sish potentsialiga ega bo'lgan past baholangan aktivlarni aniqlaydi. Amphastar Pharmaceuticals (AMPH) uchun PEG koeffitsienti tahlili biznesning faqat generik dori vositalariga yo'naltirilgan tor doiradan o'zining shaxsiy patentlangan dori yetkazib berish tizimlarini joriy etishga o'tish davridagi barqarorligini tasdiqlaydi.
Amphastar Pharmaceuticals raqobatchilari
HLN (Haleon PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - O‘sish sur’atiga tuzatilgan narx-foyda|MENS: Narx-foyda va o‘sish multiplikatori|ligand.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|AMRX: PEG multiplikatori|Perrigo Company PLC - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ALVO (Alvotech Corp) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Liquidia Inc. LQDA|Narxning foydaga va o‘sish sur’atiga nisbati Galapagos NV (GLPG)|ANIP (anipharmaceuticals.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori MNKD (MannKind)|PEG multiplikatori Pacira Pharmaceuticals PCRX|SPRY - Narxning foydaga va o‘sish sur’atiga nisbati|Theravance Corp (TBPH) - Narx-foyda va o‘sish multiplikatori|Aquestive Therapeutics (AQST) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati SCPH (scPharmaceuticals)|TECX (Tectonic Therapeutic Inc.) - PEG multiplikatori|TNXP: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori SXTC|PEG multiplikatori eupraxiapharma.com (EPRX)|Narxning foydaga va o‘sish sur’atiga nisbati BioHarvest Sciences BHST|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati invizyne.com (EXOZ)|ORMP: Narx-foyda va o‘sish multiplikatori|Entera Bio Ltd. - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|HYFT: PEG multiplikatori|ABVC BioPharma, Inc (ABVC) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Cumberland Pharmaceuticals|QNTM: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Rani Therapeutics Holdings, Inc. RANI|SNYR (Synergy CHC Corp.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Rallybio Corp. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti LEXX (Lexaria Bioscience)|PULM: PEG multiplikatori|Pheton Holdings (PTHL) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Aptorum Group Ltd|LYRA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Impact BioMedical Inc (IBO)|Narx-foyda va o‘sish multiplikatori tnfpharma.com TNFA|PEG multiplikatori YCBD (cbdMD)|PEG multiplikatori PainReform Ltd PRFX|Auris Medical - PEG multiplikatori|Lipella Pharma (LIPO) - Narx-foyda va o‘sish multiplikatori|OPTN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda pieris.com (PIRS)|Narx-foyda va o‘sish multiplikatori PROC|PEG multiplikatori Petros Pharmaceuticals Inc|Narx-foyda va o‘sish multiplikatori QLI (Qilian International Holding Group Limited)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SLRN|PEG multiplikatori TFFP (TFF Pharmaceuticals)
